David Roth
CIK 1599014 · Chief Medical Officer · last filed 2024-11-20
David Roth is a Chief Medical Officer who has filed 19 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing shows the insider sold $2.4K of SYRS on Nov 20, 2024. Across all open-market trades the lifetime net is −$139.8K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
19
-$139.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SYRS | Chief Medical Officer | 0 | $0.00 | $0 | -$139.8K | 18 | 2024-11-20 |
| INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Chief Medical Officer | — | $0.04 | — | $0 | 1 | 2015-01-16 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-11-20 | SYRS | Sell (S) | −12,099 | -$2.4K | EDGAR |
| 2024-11-04 | SYRS | Mixed | +12,099 | -$14.2K | EDGAR |
| 2024-04-05 | SYRS | Sell (S) | −10,451 | -$51.7K | EDGAR |
| 2024-04-02 | SYRS | Mixed | +10,451 | -$25.0K | EDGAR |
| 2023-12-14 | SYRS | Sell (S) | −6,287 | -$31.1K | EDGAR |
| 2023-12-08 | SYRS | Sell (S) | −6,287 | -$24.8K | EDGAR |
| 2023-11-02 | SYRS | Mixed | +12,574 | -$14.0K | EDGAR |
| 2023-08-02 | SYRS | Sell (S) | −7,348 | -$29.0K | EDGAR |
| 2023-04-04 | SYRS | Mixed | +1,377 | -$1.6K | EDGAR |
| 2023-02-21 | SYRS | Grant (A) | — | $0 | EDGAR |